FDA warns about severe worsening of multiple sclerosis after stopping the medicine Gilenya (fingolimod)

FDA warns about severe worsening of multiple sclerosis after stopping the medicine Gilenya (fingolimod)
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Source Type: news